Transcellular biosynthesis of eicosanoid lipid mediators
- PMID: 25218301
- DOI: 10.1016/j.bbalip.2014.09.002
Transcellular biosynthesis of eicosanoid lipid mediators
Abstract
The synthesis of oxygenated eicosanoids is the result of the coordinated action of several enzymatic activities, from phospholipase A2 that releases the polyunsaturated fatty acids from membrane phospholipids, to primary oxidative enzymes, such as cyclooxygenases and lipoxygenases, to isomerases, synthases and hydrolases that carry out the final synthesis of the biologically active metabolites. Cells possessing the entire enzymatic machinery have been studied as sources of bioactive eicosanoids, but early on evidence proved that biosynthetic intermediates, albeit unstable, could move from one cell type to another. The biosynthesis of bioactive compounds could therefore be the result of a coordinated effort by multiple cell types that has been named transcellular biosynthesis of the eicosanoids. In several cases cells not capable of carrying out the complete biosynthetic process, due to the lack of key enzymes, have been shown to efficiently contribute to the final production of prostaglandins, leukotrienes and lipoxins. We will review in vitro studies, complex functional models, and in vivo evidences of the transcellular biosynthesis of eicosanoids and the biological relevance of the metabolites resulting from this unique biosynthetic pathway. This article is part of a Special Issue entitled "Oxygenated metabolism of PUFA: analysis and biological relevance".
Keywords: Arachidonic acid; Cyclooxygenases; Eicosanoids; Lipoxygenases; Transcellular biosynthesis.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses.Pharmacol Rev. 2006 Sep;58(3):375-88. doi: 10.1124/pr.58.3.8. Pharmacol Rev. 2006. PMID: 16968946 Review.
-
Transcellular biosynthesis of eicosanoids.Pharmacol Rep. 2010 May-Jun;62(3):503-10. doi: 10.1016/s1734-1140(10)70306-6. Pharmacol Rep. 2010. PMID: 20631414 Free PMC article. Review.
-
Vascular biology of eicosanoids and atherogenesis.Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1079-89. doi: 10.1586/erc.09.91. Expert Rev Cardiovasc Ther. 2009. PMID: 19764861 Review.
-
Factors influencing the eicosanoids synthesis in vivo.Biomed Res Int. 2015;2015:690692. doi: 10.1155/2015/690692. Epub 2015 Mar 11. Biomed Res Int. 2015. PMID: 25861641 Free PMC article. Review.
-
The role of eicosanoids in the brain.Asia Pac J Clin Nutr. 2008;17 Suppl 1:220-8. Asia Pac J Clin Nutr. 2008. PMID: 18296342 Review.
Cited by
-
In Vivo Cellular Phosphatidylcholine Kinetics of CD15+ Leucocytes and CD3+ T-Lymphocytes in Adults with Acute Respiratory Distress Syndrome.Cells. 2024 Feb 11;13(4):332. doi: 10.3390/cells13040332. Cells. 2024. PMID: 38391944 Free PMC article.
-
Frankincense preparation promotes formation of inflammation-resolving lipid mediators by manipulating lipoxygenases in human innate immune cells.Front Pharmacol. 2024 Jan 4;14:1332628. doi: 10.3389/fphar.2023.1332628. eCollection 2023. Front Pharmacol. 2024. PMID: 38239198 Free PMC article.
-
Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators.Front Pharmacol. 2023 Aug 23;14:1219160. doi: 10.3389/fphar.2023.1219160. eCollection 2023. Front Pharmacol. 2023. PMID: 37680719 Free PMC article.
-
Dietary Implications of Polyunsaturated Fatty Acids during Pregnancy and in Neonates.Life (Basel). 2023 Jul 29;13(8):1656. doi: 10.3390/life13081656. Life (Basel). 2023. PMID: 37629513 Free PMC article. Review.
-
Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks.iScience. 2023 Jul 18;26(8):107422. doi: 10.1016/j.isci.2023.107422. eCollection 2023 Aug 18. iScience. 2023. PMID: 37575177 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources